FibroGen Inc (FGEN)
1.21
+0.06
(+5.22%)
USD |
NASDAQ |
May 31, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
FibroGen Revenue (TTM): 167.49M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 167.49M |
December 31, 2023 | 147.75M |
September 30, 2023 | 154.98M |
June 30, 2023 | 130.58M |
March 31, 2023 | 116.07M |
December 31, 2022 | 140.74M |
September 30, 2022 | 122.91M |
June 30, 2022 | 263.15M |
March 31, 2022 | 257.71M |
December 31, 2021 | 235.31M |
September 30, 2021 | 283.76M |
June 30, 2021 | 171.82M |
March 31, 2021 | 190.35M |
December 31, 2020 | 176.32M |
September 30, 2020 | 119.30M |
June 30, 2020 | 108.44M |
March 31, 2020 | 257.12M |
December 31, 2019 | 256.58M |
September 30, 2019 | 356.66M |
June 30, 2019 | 352.51M |
Date | Value |
---|---|
March 31, 2019 | 204.90M |
December 31, 2018 | 212.96M |
September 30, 2018 | 135.64M |
June 30, 2018 | 147.16M |
March 31, 2018 | 133.48M |
December 31, 2017 | 131.00M |
September 30, 2017 | 135.78M |
June 30, 2017 | 125.34M |
March 31, 2017 | 184.35M |
December 31, 2016 | 183.19M |
September 30, 2016 | 172.11M |
June 30, 2016 | 161.54M |
March 31, 2016 | 192.81M |
December 31, 2015 | 180.83M |
September 30, 2015 | 172.49M |
June 30, 2015 | 166.62M |
March 31, 2015 | 136.02M |
December 31, 2014 | 137.60M |
September 30, 2014 | 133.89M |
June 30, 2014 | 191.47M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
108.44M
Minimum
Jun 2020
356.66M
Maximum
Sep 2019
200.48M
Average
174.07M
Median
Revenue (TTM) Benchmarks
Annovis Bio Inc | -- |
Emergent BioSolutions Inc | 1.158B |
Vertex Pharmaceuticals Inc | 10.18B |
Geron Corp | 0.52M |
Nanoviricides Inc | -- |